- Home
- KNSA vs RITM Comparison
KNSA vs RITM Comparison
Compare KNSA & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | RITM |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.2B |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | KNSA | RITM |
|---|---|---|
| Price | $79.55 | $8.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $98.00 | $13.10 |
| AVG Volume (30 Days) | 408.7K | ★ 6.0M |
| Earning Date | 10-27-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 11.60% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | 0.16 |
| Revenue | $677,564,000.00 | ★ $4,590,228,000.00 |
| Revenue This Year | $46.66 | $54.34 |
| Revenue Next Year | $22.90 | $7.98 |
| P/E Ratio | $291.67 | ★ $53.88 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $35.53 | $8.40 |
| 52 Week High | $82.94 | $12.15 |
Technical Indicators
Market Signals| Indicator | KNSA | RITM |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 28.83 |
| Support Level | $73.81 | $8.43 |
| Resistance Level | $81.42 | $9.49 |
| Average True Range (ATR) | 2.60 | 0.21 |
| MACD | 0.30 | -0.04 |
| Stochastic Oscillator | 86.28 | 16.41 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.